lutetium has been researched along with fluorodeoxyglucose f18 in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (46.67) | 29.6817 |
2010's | 6 (40.00) | 24.3611 |
2020's | 2 (13.33) | 2.80 |
Authors | Studies |
---|---|
Bossuyt, A; Caveliers, V; Everaert, H; Franken, PR; Lahoutte, T; Muylle, K; Vanhove, C | 1 |
Boellaard, R; Comans, EF; Hoekstra, OS; Joshi, U; Miller, SD; Pijpers, RJ; Raijmakers, PG; Teule, GJ; van Lingen, A | 1 |
Czernin, J; Dahlbom, M; Halpern, BS; Quon, A; Ratib, O; Schiepers, C; Silverman, DH; Waldherr, C | 1 |
Boerdijk, SM; Paans, AM; Pruim, J; Willemsen, AT | 1 |
Auerbach, MA; Czernin, J; Dahlbom, M; Fueger, BJ; Halpern, BS; Ratib, O; Schiepers, C; Silverman, DH; Weber, WA | 1 |
Badawi, RD; Dibos, PE; Gilbert, R; Line, BR; Lodge, MA | 1 |
Inoue, T; Kawano, T; Ohtake, E | 1 |
Bleichrodt, R; Boerman, O; de Jong, G; Franssen, G; Hendriks, T; Oyen, W | 1 |
Junnarkar, SS; Maramraju, SH; Pratte, JF; Purschke, ML; Ravindranath, B; Rescia, S; Schlyer, DJ; Schulz, D; Smith, SD; Southekal, S; Stoll, S; Vaska, P; Woody, CL | 1 |
Matsutomo, N; Nagaki, A; Onoguchi, M | 1 |
Choyke, PL; Green, MV; Jagoda, EM; Kakareka, JW; Pohida, TJ; Seidel, J; Xi, W | 1 |
Bai, X; Bec, J; Cherry, SR; Di, K; Dokhale, P; Farrell, R; Judenhofer, MS; Qi, J; Rodriguez, M; Shah, KS; Wu, Y; Yang, Y; Zhang, M; Zhou, J | 1 |
Bakshi, G; Banerjee, S; Basu, S; Joshi, A; Parghane, RV; Prabhash, K; Suman, S; Talole, S | 1 |
Alberts, I; Bharkhada, D; Conti, M; Mingels, C; Panin, V; Prenosil, G; Rominger, A; Sari, H; Shi, K; Teimoorisichani, M; Xue, S | 1 |
D'Alessandria, C; Eiber, M; Haller, B; Heck, M; Karimzadeh, A; Knorr, K; Nekolla, S; Rauscher, I; Solaris, E; Tauber, R; Weber, WA | 1 |
3 trial(s) available for lutetium and fluorodeoxyglucose f18
Article | Year |
---|---|
Initial experience with a prototype dual-crystal (LSO/NaI) dual-head coincidence camera in oncology.
Topics: Adult; Aged; Aged, 80 and over; Equipment Design; Equipment Failure Analysis; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lutetium; Male; Middle Aged; Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Silicates; Sodium Iodide; Transducers; Whole-Body Counting | 2004 |
Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.
Topics: Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lutetium; Male; Middle Aged; Neoplasms; Obesity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Silicates; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
The Impact of PSMA PET-Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy.
Topics: Dipeptides; Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Treatment Outcome | 2023 |
12 other study(ies) available for lutetium and fluorodeoxyglucose f18
Article | Year |
---|---|
Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.
Topics: Dose-Response Relationship, Drug; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lutetium; Male; Middle Aged; Neoplasms; Quality Control; Radiation Protection; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Silicates; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.
Topics: Body Weight; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lutetium; Male; Middle Aged; Neoplasms; Posture; Prospective Studies; Radiopharmaceuticals; Silicates; Time Factors; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Source of impaired image quality in 3D whole-body FDG PET scanning.
Topics: Artifacts; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Lutetium; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Quality Control; Radiation Protection; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Silicates; Whole-Body Counting | 2004 |
Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner.
Topics: Equipment Design; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lutetium; Male; Medical Oncology; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Silicates; Whole Body Imaging | 2006 |
Deep-inspiration breath-hold PET/CT of lung cancer: maximum standardized uptake value analysis of 108 patients.
Topics: Aged; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Inhalation; Lung Neoplasms; Lutetium; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Silicates; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Adjuvant radioimmunotherapy after radiofrequency ablation of colorectal liver metastases in an experimental model.
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Disease Models, Animal; Fluorodeoxyglucose F18; Liver Neoplasms; Lutetium; Male; Octreotide; Positron-Emission Tomography; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Rats; Reproducibility of Results; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2011 |
Small animal simultaneous PET/MRI: initial experiences in a 9.4 T microMRI.
Topics: Animals; Brain; Calibration; Female; Fluorodeoxyglucose F18; Heart; Lutetium; Magnetic Resonance Imaging; Male; Mice; Phantoms, Imaging; Positron-Emission Tomography; Raclopride; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Silicates | 2011 |
Patient weight-based acquisition protocols to optimize (18)F-FDG PET/CT image quality.
Topics: Body Weight; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lutetium; Male; Middle Aged; Positron-Emission Tomography; Quality Control; Retrospective Studies; Silicates; Tomography, X-Ray Computed | 2011 |
Performance characteristics of a positron projection imager for mouse whole-body imaging.
Topics: Animals; Electrons; Fluorides; Fluorodeoxyglucose F18; Linear Models; Lutetium; Mice; Phantoms, Imaging; Time Factors; Whole Body Imaging | 2013 |
A Prototype High-Resolution Small-Animal PET Scanner Dedicated to Mouse Brain Imaging.
Topics: Animals; Brain; Electronics; Equipment Design; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Lutetium; Mice; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Silicates | 2016 |
Therapeutic efficacy, prognostic variables and clinical outcome of
Topics: Aged; Aged, 80 and over; Antigens, Surface; Dipeptides; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2019 |
Quantitative evaluation of a deep learning-based framework to generate whole-body attenuation maps using LSO background radiation in long axial FOV PET scanners.
Topics: Background Radiation; Deep Learning; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lutetium; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Water | 2022 |